Invention Grant
- Patent Title: TLR4 agonists and compositions thereof and their use in the treatment of cancer
-
Application No.: US15749854Application Date: 2016-06-03
-
Publication No.: US10765690B2Publication Date: 2020-09-08
- Inventor: Christopher W. Cluff , Hua-Xin Gao
- Applicant: GlaxoSmithKline Intellectual Property Development Limited
- Applicant Address: GB Brentford, Middlesex
- Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee Address: GB Brentford, Middlesex
- Agent Robert J. Smith
- International Application: PCT/IB2016/053290 WO 20160603
- International Announcement: WO2017/021792 WO 20170209
- Main IPC: A61K31/7032
- IPC: A61K31/7032 ; A61P35/00 ; A61K31/407 ; A61K45/06 ; A61K31/675 ; A61K9/00 ; A61K39/395 ; C07K16/28 ; A61K39/00
Abstract:
Disclosed is a TLR4 agonist alone or in combination with an anti-cancer agent and pharmaceutical compositions thereof, uses thereof, and methods of treatment comprising administering said composition or combination, including uses in cancer.
Public/Granted literature
- US20180221399A1 TLR4 agonists and compositions thereof and their use in the treatment of cancer Public/Granted day:2018-08-09
Information query
IPC分类:
